Invention Grant
US07642342B2 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
失效
核酸和相应的标题为161P5C5的蛋白质可用于治疗和检测癌症
- Patent Title: Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
- Patent Title (中): 核酸和相应的标题为161P5C5的蛋白质可用于治疗和检测癌症
-
Application No.: US11442031Application Date: 2006-05-26
-
Publication No.: US07642342B2Publication Date: 2010-01-05
- Inventor: Pia M. Challita-Eid , Arthur B. Raitano , Mary Faris , Rene S. Hubert , Karen Jane Meyrick Morrison , Robert Kendall Morrison , Wangmao Ge , Aya Jakobovits
- Applicant: Pia M. Challita-Eid , Arthur B. Raitano , Mary Faris , Rene S. Hubert , Karen Jane Meyrick Morrison , Robert Kendall Morrison , Wangmao Ge , Aya Jakobovits
- Applicant Address: US CA Santa Monica
- Assignee: Agensys, Inc.
- Current Assignee: Agensys, Inc.
- Current Assignee Address: US CA Santa Monica
- Agency: Morrison & Foerster LLP
- Main IPC: C07H21/02
- IPC: C07H21/02
Abstract:
A novel gene (designated 161P5C5) and its encoded protein, and variants thereof, are described wherein 161P5C5 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table 1. Consequently, 161P5C5 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P5C5 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P5C5 can be used in active or passive immunization.
Public/Granted literature
- US20080280822A1 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer Public/Granted day:2008-11-13
Information query
